Miscellaneous Antibacterial Drugs

Emily C. Tucker, Matthew B. Roberts, Nicola A. Sweeney, David L. Gordon

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    1 Citation (Scopus)


    This review of the January 2017 to December 2017 publications on miscellaneous antibacterial drugs covers aminoglycosides (amikacin, gentamicin, paromomycin and tobramycin), fluoroquinolones (ciprofloxacin, levofloxacin and moxifloxacin), glycopeptides (dalbavancin, telavancin, teicoplanin and vancomycin), ketolides (solithromycin), the lincosamide clindamycin, macrolides (azithromycin, clarithromycin, erythromycin), oxazolidinones (linezolid and tedizolid), polymixins (colistin and polymyxin B), trimethoprim, trimethoprim–sulfamethoxazole and daptomycin.

    Original languageEnglish
    Title of host publicationSide Effects of Drugs Annual
    Subtitle of host publicationA worldwide yearly survey of new data in adverse drug reactions
    EditorsSidhartha D. Ray
    PublisherElsevier B.V.
    Number of pages15
    ISBN (Print)9780444641199, 044464119X
    Publication statusPublished - 2018

    Publication series

    NameSide Effects of Drugs Annual
    ISSN (Print)0378-6080


    • Aminoglycosides
    • Clindamycin
    • Daptomycin
    • Fluoroquinolones
    • Glycopeptides
    • Linezolid
    • Macrolides
    • Polymyxins
    • Solithromycin
    • Tedizolid
    • Trimethoprim
    • Trimethoprim–sulfamethoxazole


    Dive into the research topics of 'Miscellaneous Antibacterial Drugs'. Together they form a unique fingerprint.

    Cite this